Benefit–cost analysis of an integrated package of interventions during preconception, pregnancy and early childhood in India
Open Access
- 12 April 2025
- journal article
- Published by BMJ in BMJ Global Health
- Vol. 10 (4) , e013659
Abstract
Background: We have previously shown that an integrated intervention package delivered during preconception, pregnancy and early childhood substantially reduces low birth weight and stunting at 24 months of age compared with routine care. Now we conduct a benefit–cost analysis to estimate the return on investment of this integrated approach in India. This increases the policy relevance of trial results, given the low investment in healthcare in India. Methods: We used data from 13 500 participants in the Women and Infant Integrated Interventions for Growth Study (WINGS). Integrated delivery of healthcare, nutrition, water, sanitation and hygiene (WaSH), and psychosocial care interventions during preconception period, or pregnancy and early childhood, or both (full package), was compared with routine care. We converted reduction in mortality, morbidity and increase in productivity to monetary values and calculated the benefit–cost ratio. We used primary and secondary trial health outcomes from the WINGS trial to calculate benefits, and we collected costs prospectively during the trial. Uncertainty was explored in a one-way sensitivity analysis. We applied a discount rate of 3% per annum to both costs and benefits, considering the purchasing power parity (PPP) of US dollars in 2021. Results: Every dollar invested returned 6.1$ PPP for interventions during preconception, 9.9$ PPP for pregnancy and early childhood interventions and 3.7$ PPP for the full package of interventions compared with routine care in the base case scenario. The return to investment was positive (>4.6$ PPP per 1$ PPP invested) for pregnancy and early childhood interventions in all scenarios of the sensitivity analysis. The net monetary benefits of the interventions ranged between 7364 and 25 917$ PPP. Conclusion: Our results suggest that integrated and concurrent delivery of healthcare, nutrition, WaSH and psychosocial care interventions during pregnancy and early childhood yield positive economic returns.Keywords
Funding Information
- Biotechnology Industry Research Assistance Council (BIRAC/GCI/0085/03/14-ACT)
- Bill and Melinda Gates Foundation, USA (OPP1191052)
This publication has 21 references indexed in Scilit:
- Comparison of the costs and benefits of the Clean India MissionWorld Development, 2020
- A future for the world's children? A WHO–UNICEF–Lancet CommissionThe Lancet, 2020
- The aggregate income losses from childhood stunting and the returns to a nutrition intervention aimed at reducing stuntingEconomics & Human Biology, 2019
- Income Elasticities and Global Values of a Statistical LifeJournal of Benefit-Cost Analysis, 2017
- Improved nutrition in the first 1000 days and adult human capital and healthAmerican Journal of Human Biology, 2017
- The Role of Nutrition in Brain Development: The Golden Opportunity of the “First 1000 Days”The Journal of Pediatrics, 2016
- Advancing social and economic development by investing in women's and children's health: a new Global Investment FrameworkThe Lancet, 2014
- Mortality risk in preterm and small-for-gestational-age infants in low-income and middle-income countries: a pooled country analysisThe Lancet, 2013
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task ForceValue in Health, 2013
- Measuring the value of statistical life: estimating compensating wage differentials among workers in IndiaSocial Indicators Research, 2007